Condition
Hospital Acquired Pneumonia clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Hospital Acquired Pneumonia clinical trials that are recruiting, at sites in 13 countries (most in South Korea (2), France (1), Greece (1)). By phase: Phase 3 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 13Countries
Newest Hospital Acquired Pneumonia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pneumonia After Heart Surgery: Can AI Predict It? | — | Tomsk | Recruiting | Aug 4, 2026 |
| Predictors and Outcomes of Ventilated Hospital-Acquired Pneumonia | — | Asyut, Asyut Governorate | Recruiting | Jun 25, 2026 |
| Using dexamethasone to treat severe hospital-acquired pneumonia in critically ill patients | Phase 3 | Amiens and 33 other locations | Recruiting | Feb 21, 2024 |
| Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus | Phase 3 | Freiburg im Breisgau, Baden-Wurttemberg and 27 other locations | Recruiting | Nov 18, 2023 |
| Early treatment with targeted antibiotics for severe infections using rapid diagnostics | Phase 4 | Vellore and 20 other locations | Recruiting | Aug 7, 2023 |
| Learning about the safety and effectiveness of Zavicefta in Korea | — | Seoul, Gangnam-gu | Recruiting | Feb 17, 2023 |
All recruiting trials (6)
-
Pneumonia After Heart Surgery: Can AI Predict It?
This study tests whether artificial intelligence can predict hospital-acquired pneumonia after heart surgery and whether pneumonia can indicate higher risk of future heart and lung problems.
-
Predictors and Outcomes of Ventilated Hospital-Acquired Pneumonia
This study looks at which factors predict outcomes for patients with ventilated hospital-acquired pneumonia to help guide care.
-
Using dexamethasone to treat severe hospital-acquired pneumonia in critically ill patients
This study is testing if adding dexamethasone to standard treatment helps critically ill patients with severe hospital-acquired pneumonia feel better compared to those who only get standard treatment.
-
Using acyclovir to treat pneumonia in ventilated patients with herpes simplex virus
This study is testing if giving acyclovir to ICU patients on ventilators who have pneumonia and herpes simplex virus can help them survive better than those who don't receive the medication.
-
Early treatment with targeted antibiotics for severe infections using rapid diagnostics
This study is testing if giving targeted antibiotics right away, based on quick test results, can help hospitalized patients with severe infections caused by tough-to-treat bacteria feel better faster than standard care.
-
Learning about the safety and effectiveness of Zavicefta in Korea
This study is trying to learn how safe and effective Zavicefta is for treating serious infections in both adults and kids in Korea after it has been released for use.
Related topics
Quick answers
How many Hospital Acquired Pneumonia clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 13 countries. The most sites are in South Korea (2 trials), France (1 trial), Greece (1 trial), Spain (1 trial), India (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.